IPO - Cosmos Health Inc.
Form Type: S-1/A
Filing Date: 2025-02-07
Corporate Action: Ipo
Type: Update
Accession Number: 000147793225000785
Filing Summary: This document is Amendment No. 4 to the Registration Statement on Form S-1 for Cosmos Health Inc., filed with the SEC on February 7, 2025. It includes updates and amendments to Exhibits 23.1 and 23.2, while the rest of the Registration Statement remains unchanged. The document provides the updated timeline for the commencement of the proposed sale of securities, highlighting that it will occur as soon as the Registration Statement becomes effective. Furthermore, it categorizes Cosmos Health Inc. as a Smaller Reporting Company and emphasizes its status as an Emerging Growth Company. The document outlines necessary steps for the effective date of the Registration Statement and includes information regarding the registrant's principal executive offices and its legal representatives. It also lists numerous exhibits pertaining to various agreements and consents related to the company's securities offering.
Document Link: View Document
Additional details:
Address: 5 AGIOU GEORGIOU, PILEA, THESSALONIKI, GREECE 55438
Phone Number: (312) 536-3102
Ceo Name: Grigorios Siokas
Exhibits: [{"exhibit_number":"23.1","description":"Consent of Armanino LLP"},{"exhibit_number":"23.2","description":"Consent of RBSM LLP"}]
Form Type: S-1/A
Filing Date: 2025-01-10
Corporate Action: Ipo
Type: Update
Accession Number: 000147793225000125
Filing Summary: On January 10, 2025, Cosmos Health Inc. filed an S-1/A registration statement with the SEC which provides detailed insights into its planned initial public offering (IPO). The filing includes information about the company's business operations, financials, and risks associated with the investment. Cosmos Health seeks to raise capital through the sale of shares to the public. This update reflects the company's commitment to expand its market presence and enhance its operational capabilities following SEC guidelines. The registration includes detailed financial statements and descriptions of material contracts, governance structures, and use of proceeds from the public offering.
Document Link: View Document
Form Type: CORRESP
Filing Date: 2024-12-12
Corporate Action: Ipo
Type: New
Accession Number: 000147793224008033
Filing Summary: Cosmos Health, Inc. has submitted a request to the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-1. The company aims for the registration to be effective by 4:00 p.m. (EST) on December 13, 2024. In the correspondence, Cosmos Health acknowledges that the SEC's declaration of effectiveness does not preclude them from regulatory actions regarding the filing and emphasizes their responsibility for the accuracy and adequacy of the disclosure provided in the registration statement. Furthermore, the company cannot rely on the SEC's actions as a defense in any legal proceedings related to the federal securities laws.
Document Link: View Document
Additional details:
Rule 461 Request: request for acceleration of effectiveness
Effective Date: 2024-12-13T16:00:00Z
Acknowledgement: the SEC's actions do not relieve the company from responsibility for adequacy and accuracy of the filing
Signature: Georgios Terzis, Chief Financial Officer
Comments
No comments yet. Be the first to comment!